3i, LP 13D and 13G filings for CNBX Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:12 pm Purchase | 2024-09-30 | 13G | CNBX Pharmaceuticals Inc. CNBX | 3i, LP | 3,340,428 9.900% | 20,637 (+0.62%) | Filing |
| 2024-02-13 4:27 pm Purchase | 2023-12-31 | 13G | CNBX Pharmaceuticals Inc. CNBX | 3i, LP | 3,319,791 9.900% | 3,080,811 (+1289.15%) | Filing |
| 2023-03-06 5:03 pm Purchase | 2022-11-11 | 13G | CNBX Pharmaceuticals Inc. CNBX | 3i, LP | 238,980 9.980% | 238,980 (New Position) | Filing |